Campbell & CO Investment Adviser LLC Evolus, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$10.45 - $13.76 $220,683 - $290,583
21,118 New
21,118 $229,000
Q4 2023

Feb 13, 2024
BUY
$7.6 - $10.53 $775,245 - $1.07 Million
102,006 Added 355.17%
130,726 $1.38 Million
Q3 2023

Nov 08, 2023
BUY
$7.15 - $10.2 $205,348 - $292,944
28,720 New
28,720 $262,000

Others Institutions Holding EOLS

# of Institutions
169
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $673M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email